120 related articles for article (PubMed ID: 8091636)
21. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
22. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
[TBL] [Abstract][Full Text] [Related]
23. In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA.
Guardabassi L; Ghibaudo G; Damborg P
Vet Dermatol; 2010 Jun; 21(3):282-6. PubMed ID: 20030799
[TBL] [Abstract][Full Text] [Related]
24. Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.
Hamoud R; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2014 Mar; 21(4):443-7. PubMed ID: 24262063
[TBL] [Abstract][Full Text] [Related]
25. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Chan WY; Khazandi M; Hickey EE; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2019 Apr; 30(2):133-e38. PubMed ID: 30548715
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015.
Xu Z; Xie J; Peters BM; Li B; Li L; Yu G; Shirtliff ME
Microb Pathog; 2017 Feb; 103():80-86. PubMed ID: 27894963
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial action of combinations of oxytetracycline, dimethyl sulfoxide, and EDTA-tromethamine on Proteus, Salmonella, and Aeromonas.
Wooley RE; Gilbert JP; Shotts EB
Am J Vet Res; 1982 Jan; 43(1):130-3. PubMed ID: 6807142
[TBL] [Abstract][Full Text] [Related]
28. In vitro antimicrobial activity of a gel containing antimicrobial peptide AMP2041, chlorhexidine digluconate and Tris-EDTA on clinical isolates of Pseudomonas aeruginosa from canine otitis.
Ghibaudo G; Santospirito D; Sala A; Flisi S; Taddei S; Cavirani S; Cabassi CS
Vet Dermatol; 2016 Oct; 27(5):391-e98. PubMed ID: 27545352
[TBL] [Abstract][Full Text] [Related]
29. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
30. In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin.
Bouanchaud DH
J Antimicrob Chemother; 1997 May; 39 Suppl A():15-21. PubMed ID: 9511057
[TBL] [Abstract][Full Text] [Related]
31. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.
Nakashio S; Iwasawa H; Dun FY; Kanemitsu K; Shimada J
Drugs Exp Clin Res; 1995; 21(1):7-16. PubMed ID: 7796712
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
Severina E; Severin A; Tomasz A
J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
[TBL] [Abstract][Full Text] [Related]
33. Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions.
Clark SM; Loeffler A; Schmidt VM; Chang YM; Wilson A; Timofte D; Bond R
Vet Dermatol; 2016 Oct; 27(5):340-e84. PubMed ID: 27406860
[TBL] [Abstract][Full Text] [Related]
34. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
Kroemer S; El Garch F; Galland D; Petit JL; Woehrle F; Boulouis HJ
Comp Immunol Microbiol Infect Dis; 2014 Mar; 37(2):97-108. PubMed ID: 24447508
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
37. Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential.
Rubinstein E; Bompart F
J Antimicrob Chemother; 1997 May; 39 Suppl A():139-43. PubMed ID: 9511078
[TBL] [Abstract][Full Text] [Related]
38. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
39. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-EDTA new combination is a promising candidate for treatment of bacterial and fungal infections.
El-Sharif AA; Hussain MH
Curr Microbiol; 2011 Mar; 62(3):739-45. PubMed ID: 20963418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
